Vivos RDGL
OTC RDGL
$0.06 0.00 (-1.13%)
At close: Aug 19, 2026 · 3:54 PM UTC

Vivos (RDGL) Cash from Investing Activities Growth (3y) (2013)

Vivos (RDGL) Cash from Investing Activities Growth (3y) (2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 199.46 Bn 193.86 Bn 7.27 Bn 17.83%
2 Stryker 127.41 Bn 123.93 Bn 4.50 Bn -6.23%
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn -24.52%
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn -32.54%
5 Edwards Lifesciences 51.95 Bn 47.69 Bn 1.35 Bn -68.12%
6 Dexcom 34.30 Bn 32.35 Bn 830.00 Mn 37.39%
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn -11.04%
8 Koninklijke Philips 26.35 Bn 23.02 Bn 4.55 Bn 19.58%
9 Steris 23.04 Bn 22.55 Bn 684.20 Mn -17.67%
10 Vivos 24.90 Mn 23.34 Mn -3,105.00 -

Historic Data

Download Data
DateValue
Dec 31, 2013 -25.99%